X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (21) 21
index medicus (16) 16
oncology (12) 12
female (11) 11
adult (10) 10
male (10) 10
hematology (7) 7
hematology, oncology and palliative medicine (7) 7
middle aged (7) 7
stem cells (7) 7
transplantation (7) 7
transplantation, homologous (7) 7
leukemia (6) 6
stem-cell transplantation (6) 6
stem-cells (6) 6
animals (5) 5
bone marrow (5) 5
analysis (4) 4
cancer (4) 4
cell biology (4) 4
hematopoietic stem cells (4) 4
mice (4) 4
research (4) 4
treatment outcome (4) 4
adolescent (3) 3
bone-marrow (3) 3
bone-marrow-transplantation (3) 3
clinical trials (3) 3
development and progression (3) 3
expression (3) 3
gene expression (3) 3
hematopoietic stem cell transplantation (3) 3
hematopoietic stem cell transplantation - methods (3) 3
immunology (3) 3
leukemia, myeloid, acute - drug therapy (3) 3
leukemia, myeloid, acute - mortality (3) 3
medicine (3) 3
medicine, research & experimental (3) 3
proliferation (3) 3
prospective studies (3) 3
t-lymphocytes - immunology (3) 3
therapy (3) 3
versus-host-disease (3) 3
acute lymphoblastic-leukemia (2) 2
acute lymphocytic leukemia (2) 2
acute myelogenous leukemia (2) 2
advanced basic science (2) 2
age factors (2) 2
bone metastases (2) 2
bone neoplasms - secondary (2) 2
care and treatment (2) 2
cell & tissue engineering (2) 2
cell differentiation (2) 2
cell line, tumor (2) 2
cell proliferation (2) 2
cells, cultured (2) 2
chemotherapy (2) 2
cytarabine - therapeutic use (2) 2
differentiation (2) 2
disease-free survival (2) 2
drug therapy, combination (2) 2
extracellular matrix (2) 2
gene-expression (2) 2
genetic aspects (2) 2
genetic engineering (2) 2
hematopoietic stem cells - cytology (2) 2
hematopoietic stem cells - metabolism (2) 2
host-disease (2) 2
in-vitro (2) 2
interferon-gamma (2) 2
leukemia, myeloid, acute - therapy (2) 2
lymphocytes (2) 2
medical prognosis (2) 2
medicine & public health (2) 2
medicine, general & internal (2) 2
mesenchymal stromal cells - cytology (2) 2
mortality (2) 2
natural-killer-cells (2) 2
osteogenesis (2) 2
peptides (2) 2
physiological aspects (2) 2
progenitor cells (2) 2
prognosis (2) 2
prostate cancer (2) 2
proto-oncogene proteins - physiology (2) 2
recurrence (2) 2
research article (2) 2
risk (2) 2
risk assessment (2) 2
risk factors (2) 2
severity of illness index (2) 2
standards (2) 2
stromal cells - cytology (2) 2
stromal cells - metabolism (2) 2
survival (2) 2
survival analysis (2) 2
t cells (2) 2
time factors (2) 2
tissue (2) 2
transplantation conditioning (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1691 - 1699
Summary Background Preclinical data and results from non-randomised trials suggest that the multikinase inhibitor sorafenib might be an effective drug for the... 
Hematology, Oncology and Palliative Medicine | AML | ONCOLOGY | ACUTE MYELOGENOUS LEUKEMIA | BONE-MARROW | CLASSIFICATION | FLT3 MUTATIONS | CYTARABINE | STEM-CELL TRANSPLANTATION | COMBINATION | ELDERLY-PATIENTS | CHEMOTHERAPY | Niacinamide - analogs & derivatives | Recurrence | Age Factors | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Transplantation, Homologous | Neoadjuvant Therapy - mortality | Time Factors | Phenylurea Compounds - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Chemotherapy, Adjuvant | Daunorubicin - therapeutic use | Double-Blind Method | Risk Factors | Kaplan-Meier Estimate | Niacinamide - adverse effects | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Treatment Outcome | Disease Progression | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Leukemia, Myeloid, Acute - diagnosis | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Protein Kinase Inhibitors - therapeutic use | Germany | Antimitotic agents | Clinical trials | Chemotherapy | Antineoplastic agents | Standards | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 9, pp. 855 - 864
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 10, pp. 1035 - 1044
Journal Article
Journal Article
Annals of Hematology, ISSN 0939-5555, 9/2014, Volume 93, Issue 9, pp. 1579 - 1586
Journal Article
Journal Article